Bank of America
MNPR icon

Bank of America’s Monopar Therapeutics MNPR Stock Holding History

Bank of America’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.27M Buy
59,699
+53,336
+838% +$3.22M ﹤0.01% 3776
2025
Q4 		$416K Buy
6,363
+4,239
+200% +$346K ﹤0.01% 5011
2025
Q3 		$173K Buy
2,124
+15
+0.7% +$671 ﹤0.01% 6353
2025
Q2 		$75.5K Sell
2,109
-369
-15% -$13.4K ﹤0.01% 6651
2025
Q1 		$90.2K Buy
2,478
+2,450
+8,750% +$88.3K ﹤0.01% 6529
2024
Q4 		$616 Buy
28
+15
+115% +$252 ﹤0.01% 7371
2024
Q3 		$88 Sell
13
-99
-88% -$331 ﹤0.01% 7741
2024
Q2 		$410 Buy
112
+12
+12% +$42 ﹤0.01% 7391
2024
Q1 		$340 Buy
+100
New +$298 ﹤0.01% 7308
2023
Q1 		– Sell
-2
Closed -$24 – 8099
2022
Q4 		$24 Buy
+2
New +$24 ﹤0.01% 7947
2022
Q1 		– Sell
-1
Closed – – 8566
2021
Q4 		$0 Buy
+1
New +$22 ﹤0.01% 8468

Other funds holding MNPR

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bank of America's MNPR Position: Q1 2026 in Review

Bank of America increased its Monopar Therapeutics (MNPR) stake by 838% in Q1 2026, buying an estimated $3.22M and bringing the position to 59,699 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #3776.

Bank of America first reported a position in MNPR in Q4 2021 and has held it in 11 quarters since. 82 funds tracked by Wall St. Rank hold MNPR as of Q1 2026.

  • Bank of America held 59,699 shares of Monopar Therapeutics worth $3.27M as of Q1 2026.
  • Bank of America bought 53,336 Monopar Therapeutics shares in Q1 2026, an estimated $3.22M.
  • Monopar Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3776 holding.
  • Bank of America first reported a position in Monopar Therapeutics in Q4 2021 and has held it in 11 quarters since.
  • 82 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.